Cargando…

Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. A number of targeted therapies have been approved for clinical use or are in clinical trials. Next generation sequencing (NGS) is widely applied in the identification of actionable genomic alterations and enables personalized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Wei, Yan, Chenghai, Wang, Hailong, Tang, Tom, Wang, Haifeng, Liu, Dujuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507321/ https://www.ncbi.nlm.nih.gov/pubmed/31186761 http://dx.doi.org/10.3892/ol.2019.10265

Ejemplares similares

Validation of an NGS mutation detection panel for melanoma
por: Reiman, Anne, et al.
Publicado: (2017)

Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America
por: Salvo, Mauricio, et al.
Publicado: (2021)

Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors
por: Martínez-Fernández, Paula, et al.
Publicado: (2021)

Key considerations for comprehensive validation of an RNA fusion NGS panel
por: Barua, Subit, et al.
Publicado: (2020)

Application of NGS in Diagnosis of Tuberculous Pleurisy with Multiple Negative Tests: A Case Report
por: Wu, Honglin, et al.
Publicado: (2020)

Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia
por: Ravasi, Giulia, et al.
Publicado: (2021)

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
por: Remon, Jordi, et al.
Publicado: (2020)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients
por: Vollbrecht, Claudia, et al.
Publicado: (2018)

EML4-ALK Gene Mutation Detected with New NGS Lung Cancer Panel CDx Using Sputum Cytology in a Case of Advanced NSCLC
por: Morikawa, Kei, et al.
Publicado: (2023)

Phenotype-oriented NGS panels for mucopolysaccharidoses: Validation and potential use in the diagnostic flowchart
por: Brusius-Facchin, Ana Carolina, et al.
Publicado: (2019)

Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa
por: Perez-Carro, Raquel, et al.
Publicado: (2016)

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
por: Papadopoulou, Eirini, et al.
Publicado: (2019)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs
por: Morikawa, Kei, et al.
Publicado: (2022)

Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients
por: He, Changlong, et al.
Publicado: (2021)

Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia
por: Madsen, Majbritt Busk, et al.
Publicado: (2020)

PanelDesign: Integrating Epidemiological Information into the Design of Diagnostic NGS Gene Panels
por: Schmidtke, Jörg, et al.
Publicado: (2022)

Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients
por: Montaño, Adrián, et al.
Publicado: (2020)

Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation
por: Zacchia, Miriam, et al.
Publicado: (2021)

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016)

Corrigendum: Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa
por: Perez-Carro, Raquel, et al.
Publicado: (2016)

NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders
por: Esposito, Maria Valeria, et al.
Publicado: (2021)

Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA
por: Willey, James C., et al.
Publicado: (2021)

Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel
por: Yan, Kangpeng, et al.
Publicado: (2023)

Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates
por: Huang, Xinwen, et al.
Publicado: (2022)

Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer
por: Kastrisiou, Myrto, et al.
Publicado: (2021)

Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia
por: Vicente-Garcés, Clara, et al.
Publicado: (2022)

Clinical utility of custom-designed NGS panel testing in pediatric tumors
por: Surrey, Lea F., et al.
Publicado: (2019)

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
por: Pecciarini, Lorenza, et al.
Publicado: (2023)

Panel-based NGS reveals disease-causing mutations in hearing loss patients using BGISEQ-500 platform
por: Sun, Yan, et al.
Publicado: (2019)

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
por: Sánchez‐Herrero, Estela, et al.
Publicado: (2021)

Evaluation of CNV detection tools for NGS panel data in genetic diagnostics
por: Moreno-Cabrera, José Marcos, et al.
Publicado: (2020)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
por: Vega-Garcia, Nerea, et al.
Publicado: (2020)

Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform
por: Darwanto, Agus, et al.
Publicado: (2017)

NGS-Logistics: federated analysis of NGS sequence variants across multiple locations
por: Ardeshirdavani, Amin, et al.
Publicado: (2014)

The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
por: Sharma, Neeraj, et al.
Publicado: (2021)

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes
por: Soukupova, Jana, et al.
Publicado: (2018)

Design and Validation of a Custom NGS Panel Targeting a Set of Lysosomal Storage Diseases Candidate for NBS Applications
por: La Cognata, Valentina, et al.
Publicado: (2021)

The ICR142 NGS validation series: a resource for orthogonal assessment of NGS analysis
por: Ruark, Elise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7q6gu9ga2hbtdl5h5k2q7b645a